The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
PML inhibits HIF-1α translation and neoangiogenesis through repression of mTOR
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
Ferrara, N. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0027 · Cited by 3,687
Sarbassov, D. D., Ali, S. M., Kim, D.-H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.054 · Cited by 2,665
Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1194 · Cited by 1,860
Self-citationTherapeutic stem and progenitor cell transplantation for organ vascularization and regeneration
Rafii, S., & Lyden, D. (2003) · Nature Medicine · doi:10.1038/nm0603-702 · Cited by 1,577
Self-citationKakizuka, A., Miller, W. H., Umesono, K., Warrell, R. P., Frankel, S. R., Murty, V. V. V. S., Dmitrovsky, E., & Evans, R. M. (1991) · Cell · doi:10.1016/0092-8674(91)90112-c · Cited by 1,427
Brugarolas, J., Lei, K., Hurley, R. L., Manning, B. D., Reiling, J. H., Hafen, E., Witters, L. A., Ellisen, L. W., & Kaelin, W. G. (2004) · Genes & Development · doi:10.1101/gad.1256804 · Cited by 1,384
de Thé, H., Lavau, C., Marchio, A., Chomienne, C., Degos, L., & Dejean, A. (1991) · Cell · doi:10.1016/0092-8674(91)90113-d · Cited by 1,343
HIF-1 and tumor progression: pathophysiology and therapeutics
Semenza, G. L. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02317-1 · Cited by 1,060
Ribosomal S6 Kinase Signaling and the Control of Translation
Dufner, A., & Thomas, G. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4683 · Cited by 676
mTOR-targeted therapy of cancer with rapamycin derivatives
Vignot, S., Faivre, S., Aguirre, D., & Raymond, E. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi113 · Cited by 617
Hypoxia-induced energy stress regulates mRNA translation and cell growth
Liu, L., Cash, T. P., Jones, R. G., Keith, B., Thompson, C. B., & Simon, M. C. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.010 · Cited by 607
The Role of PML in Tumor Suppression
Salomoni, P., & Pandolfi, P. P. (2002) · Cell · doi:10.1016/s0092-8674(02)00626-8 · Cited by 566
Self-citationRole of nucleophosmin in embryonic development and tumorigenesis
Grisendi, S., Bernardi, R., Rossi, M., Cheng, K., Khandker, L., Manova, K., & Pandolfi, P. P. (2005) · Nature · doi:10.1038/nature03915 · Cited by 561
Self-citationPml is essential for multiple apoptotic pathways
Wang, Z.-G., Ruggero, D., Ronchetti, S., Zhong, S., Gaboli, M., Rivi, R., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/3073 · Cited by 558
Self-citationRole of PML in Cell Growth and the Retinoic Acid Pathway
Gang Wang, Z., Delva, L., Gaboli, M., Rivi, R., Giorgio, M., Cordon-Cardo, C., Grosveld, F., & Paolo Pandolfi, P. (1998) · Science · doi:10.1126/science.279.5356.1547 · Cited by 517
Self-citationThe expanding TOR signaling network
Martin, D. E., & Hall, M. N. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.02.008 · Cited by 494
PML protein isoforms and the RBCC/TRIM motif
Jensen, K., Shiels, C., & Freemont, P. S. (2001) · Oncogene · doi:10.1038/sj.onc.1204765 · Cited by 467
Arsham, A. M., Howell, J. J., & Simon, M. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212770200 · Cited by 463
Self-citationCharacterization of a Zinc Finger Gene Disrupted by the t(15;17) in Acute Promyelocytic Leukemia
Goddard, A. D., Borrow, J., Freemont, P. S., & Solomon, E. (1991) · Science · doi:10.1126/science.1720570 · Cited by 458
Identification of a tumour suppressor network opposing nuclear Akt function
Trotman, L. C., Alimonti, A., Scaglioni, P. P., Koutcher, J. A., Cordon-Cardo, C., & Pandolfi, P. P. (2006) · Nature · doi:10.1038/nature04809 · Cited by 394
Self-citationRestraining PI3K: mTOR signalling goes back to the membrane
Harrington, L. S., Findlay, G. M., & Lamb, R. F. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.11.003 · Cited by 366
Rheb Binding to Mammalian Target of Rapamycin (mTOR) Is Regulated by Amino Acid Sufficiency
Long, X., Ortiz-Vega, S., Lin, Y., & Avruch, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500169200 · Cited by 349
PML regulates p53 stability by sequestering Mdm2 to the nucleolus
Bernardi, R., Scaglioni, P. P., Bergmann, S., Horn, H. F., Vousden, K. H., & Pandolfi, P. P. (2004) · Nature Cell Biology · doi:10.1038/ncb1147 · Cited by 347
Self-citationLoss of the Tumor Suppressor PML in Human Cancers of Multiple Histologic Origins
Gurrieri, C., Capodieci, P., Bernardi, R., Scaglioni, P. P., Nafa, K., Rush, L. J., Verbel, D. A., Cordon-Cardo, C., & Pandolfi, P. P. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh043 · Cited by 334
Self-citationCytoplasmic PML function in TGF-β signalling
Lin, H.-K., Bergmann, S., & Pandolfi, P. P. (2004) · Nature · doi:10.1038/nature02783 · Cited by 312
Self-citationPandolfi, P. P., Grignani, F., Alcalay, M., Mencarelli, A., Biondi, A., Lo‐Coco, F., Grignani, F., & Pelicci, P. G. (1991) · PubMed · Cited by 305
Self-citationThe PML growth-suppressor has an altered expression in human oncogenesis.
Koken, M. H. M., Linares‐Cruz, G., Quignon, F., Viron, A., Chelbi‐Alix, M. K., Sobczak‐Thépot, J., Juhlin, L., Degos, L., Calvo, F. M., & de Thé, H. (1995) · PubMed · Cited by 231
The acute promyelocytic leukaemia-associated PML gene is induced by interferon.
Lavau, C., Marchio, A., Fagioli, M., Jansen, J. H., Falini, B., Lebon, P., Grosveld, F. G., Pandolfi, P. P., Pelicci, P. G., & Dejean, A. (1995) · PubMed · Cited by 228
Self-citationPaglin, S., Lee, N.-Y., Nakar, C., Fitzgerald, M., Plotkin, J., Deuel, B., Hackett, N., McMahill, M., Sphicas, E., Lampen, N., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1083 · Cited by 220
Induction of the PML protein by interferons in normal and APL cells.
Chelbi‐Alix, M. K., Pelicano, L., Quignon, F., Koken, M. H. M., Venturini, L., Stadler, M., Pavlovic, J., Degos, L., & de Thé, H. (1995) · PubMed · Cited by 216
Kim, J. E., & Chen, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011511898 · Cited by 200
Corada, M., Zanetta, L., Orsenigo, F., Breviario, F., Lampugnani, M. G., Bernasconi, S., Liao, F., Hicklin, D. J., Bohlen, P., & Dejana, E. (2002) · Blood · doi:10.1182/blood.v100.3.905 · Cited by 195
Will mTOR inhibitors make it as cancer drugs?
Sawyers, C. L. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00275-7 · Cited by 190
PML nuclear bodies and apoptosis
Takahashi, Y., Lallemand-Breitenbach, V., Zhu, J., & de Thé, H. (2004) · Oncogene · doi:10.1038/sj.onc.1207533 · Cited by 168
Zhu, J., Lallemand-Breitenbach, V., & de Thé, H. (2001) · Oncogene · doi:10.1038/sj.onc.1204852 · Cited by 164
Role of Promyelocytic Leukemia (Pml) Protein in Tumor Suppression
Rego, E. M., Wang, Z.-G., Peruzzi, D., He, L.-Z., Cordon-Cardo, C., & Pandolfi, P. P. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.4.521 · Cited by 161
Self-citationHow oxygen makes its presence felt: Figure 1.Preprint
Kaelin, W. G. (2002) · Genes & Development · doi:10.1101/gad.1003602 · Cited by 158
Molecular pathways regulating mobilization of marrow-derived stem cells for tissue revascularization
Rabbany, S. Y., Heissig, B., Hattori, K., & Rafii, S. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00021-2 · Cited by 142
Self-citationAngiogenesis in Ischemic Disease
Risau, W., & Marti, H. H. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615552 · Cited by 122
Liao, F., Doody, J. F., Overholser, J. P., Finnerty, B., Bassi, R., Wu, Y. L., Dejana, E., Kussie, P. H., Böhlen, P., & Hicklin, D. J. (2002) · PubMed · Cited by 106
Regulation of Ribosomal S6 Kinase 2 by Mammalian Target of Rapamycin
Park, I., Bachmann, R. A., Shirazi, H., & Chen, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204080200 · Cited by 89
Gambacorta, M., Flenghi, L., Fagioli, M., Pileri, S. A., Leoncini, L., Bigerna, B., Pacini, R., Tanci, L. N., Pasqualucci, L., Ascani, S., et al. (1996) · Europe PMC (PubMed Central) · Cited by 80
Mechanism for IL-1β-mediated neovascularization unmasked by IL-1β knock-out mice
Amano, K., Okigaki, M., Adachi, Y., Fujiyama, S., Mori, Y., Kosaki, A., Iwasaka, T., & Matsubara, H. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.01.006 · Cited by 65
Lack of expression for the suppressor PML in human small cell lung carcinoma
Zhang, P., Chin, W., Chow, L. T. C., Chan, A. S., Yim, A. P. C., Leung, S., Mok, T. S. K., Chang, K., Johnson, P. J., & Chan, J. Y. H. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000301)85:5<599::aid-ijc1>3.0.co;2-# · Cited by 53
When hypoxia signalling meets the ubiquitin-proteasomal pathway, new targets for cancer therapy
Brahimi‐Horn, C., & Pouysségur, J. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.09.003 · Cited by 38
Cited by
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833
Targeting the phosphoinositide 3-kinase pathway in cancer
Liu, P., Cheng, H., Roberts, T. M., & Zhao, J. J. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2926 · Cited by 2,721
Hypoxia-inducible factors and the response to hypoxic stress
Majmundar, A. J., Wong, W. J., & Simon, M. C. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.022 · Cited by 2,380
Self-citationLaplante, M., & Sabatini, D. M. (2009) · Journal of Cell Science · doi:10.1242/jcs.051011 · Cited by 2,170
HIF-1: upstream and downstream of cancer metabolism
Semenza, G. L. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.10.009 · Cited by 1,372
Metadata
- Authors
- Bernardi, R., Guernah, I., Jin, D., Grisendi, S., Alimonti, A., Teruya-Feldstein, J., Cordon-Cardo, C., Celeste Simon, M., Rafii, S., & Pandolfi, P. P.
- Venue
- Nature
- Published
- 2006-08
- Volume
- 442
- Issue
- 7104
- Pages
- 779-785
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2090817847
- Cited by
- 378
- References
- 47
- FWCI
- 9.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.